![Freenome](http://xipometer.com/img/logo/f260b226476c892e77ade0da73b7b152.png)
Freenome
NewsHeat diagram
- Vecka
- Månad
- År
- Nyheter från media
- Corp news
Uppgifterna i diagrammet ovan baseras på uppgifter som härrör från vår egen XP-beräkningsmodell och kan ändras, justeras och uppdateras utan föregående meddelande
Värdering av företag
- Värdering
- Aktiepris
- Kumulativ finansiering
Uppgifterna i tabellerna och diagrammen baseras på uppgifter från offentliga källor och även om vi gör allt vi kan för att sammanställa uppgifterna, kanske de inte sammanfaller med emittentens faktiska uppgifter.
*** - För att se uppgifterna, logga in på ditt konto eller skapa ett nytt.
Kalkylator för värdering av företag
För att beräkna, ange en av parametrarna
Nyheter relaterade till Freenome4
![](http://xipometer.com/img/logo/f260b226476c892e77ade0da73b7b152.png)
Canaccord positive on Exact, Guardant after Freenome data ...
Canaccord positive on Exact, Guardant after Freenome data. See the rest of the story here. Theflyonthewall.com provides the latest financial news as it ...
https://pro.thestreet.com/thefly-newsbreaks/exas-gh-canaccord-positive-on-exact-guardant-after-freenome-data![](http://xipometer.com/img/logo/f260b226476c892e77ade0da73b7b152.png)
Exact Sciences Stock, A Cathie Wood's Play, Surges On Freenome's ...
Freenome is working on a blood-based test to detect colorectal cancer. Overall, Freenome's test proved roughly as specific as Exact Sciences' stool-based test, ...
https://www.investors.com/news/technology/exact-sciences-stock-cologuard-freenome-colon-cancer-detection/![](http://xipometer.com/img/logo/f260b226476c892e77ade0da73b7b152.png)
Freenome Announces Topline Results for PREEMPT CRC® to ...
Freenome is breaking barriers to early cancer detection with a suite of blood tests built on its multiomics platform. The company recognizes that no single ...
https://www.prnewswire.com/news-releases/freenome-announces-topline-results-for-preempt-crc-to-validate-the-first-version-of-its-blood-based-test-for-the-early-detection-of-colorectal-cancer-302105203.html![](http://xipometer.com/img/logo/f260b226476c892e77ade0da73b7b152.png)
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Roche led the financing, joined by a16z Life Sciences Growth Fund ...
https://www.prnewswire.com/news-releases/freenome-raises-254-million-in-new-funding-to-accelerate-its-platform-for-early-cancer-detection-302062419.html![](/img/loader.gif)
Investerare23
![Andreessen Horowitz](http://xipometer.com/img/investor/cf18c9ac72d948990cd0ce762867375d.jpeg)
![Third Kind Venture Capital](http://xipometer.com/img/investor/8c96cf58adeb989817b1ccba3399573c.jpeg)
![Founders Fund](http://xipometer.com/img/investor/7421fc27bbac02eb3994022794352479.jpeg)
![Data Collective DCVC](http://xipometer.com/img/investor/c675683aa4ac1698b68e40ffd0f1830d.jpeg)
![Polaris Partners](http://xipometer.com/img/investor/da72ce7f6fe1401b3974ac043c5d511d.jpeg)
![S28 Capital](http://xipometer.com/img/investor/4d10103d2c681f06562f93edbeb14f9e.jpeg)
![AME Cloud Ventures](http://xipometer.com/img/investor/44ea8b41035b74208c7e83b40caecd34.jpeg)
![Charles River Associates](http://xipometer.com/img/investor/71cd615cd971781e6273c838bed69f7a.jpeg)
![Allen & Company](http://xipometer.com/img/investor/807c23adf42e923cca3210358b9b8ce7.jpeg)
![GV](http://xipometer.com/img/investor/13284224598eebd685c01f16fea285fa.jpeg)
![Asset Management Ventures (AMV)](http://xipometer.com/img/investor/3b5382f0d2a97486cd0b2203ec8bf21b.jpeg)
![Innovation Endeavors](http://xipometer.com/img/investor/aa07ddc128a3bfa312505128ac7e7592.jpeg)
![CRV](http://xipometer.com/img/investor/f30e2acfaa0573fcdc3b9ebf1df0c1d0.jpeg)
![Verily](http://xipometer.com/img/investor/9edec921fafed854fc4016f845d1caee.jpeg)
![Section 32](http://xipometer.com/img/investor/a237de27401747ceb8255a668dbb13ec.jpeg)
![Artis Ventures (AV)](http://xipometer.com/img/investor/f388c42e374142e7c70f91fe1c4035fa.jpeg)
![T. Rowe Price](http://xipometer.com/img/investor/97d483cb301edf0426a420c0669f1eb5.jpeg)
![BrightEdge Fund](http://xipometer.com/img/investor/9c8904444e4c8fc8b1c98c8ff9079e77.jpeg)
![Roche Venture Fund](http://xipometer.com/img/investor/ac544bac4f4c8286334d509b47febbcd.jpeg)
![Kaiser Permanente Ventures](http://xipometer.com/img/investor/f23c63f203c9ee4269d3813edf6680ee.jpeg)
![RA Capital Management](http://xipometer.com/img/investor/c44a9359f6da1c5809bc8b24fc36fc1e.jpeg)
![Perceptive Advisors](http://xipometer.com/img/investor/74001860fd831df9c5f10e9d5204053d.jpeg)
![Loxbridge Research](http://xipometer.com/img/investor/f1dd037f6ff2224f246392a7f5997350.jpeg)